Evidence map›Paper›PMID 38586172›Full record

ArticleFrontiers in cardiovascular medicine2024

Significance of the Wnt signaling pathway in coronary artery atherosclerosis.

Kashif Khan, Bin Yu, Jean-Claude Tardif, Eric Rhéaume, Hamood Al-Kindi, Sabin Filimon, Cristina Pop, Jacques Genest, Renzo Cecere, Adel Schwertani

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Considerations on the Development of Therapeutics in Vascular Calcification.Journal of cardiovascular development and disease · 2025
    Review
  6. Role of Sclerostin in Cardiovascular System.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kashif KhanCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Bin YuCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Jean-Claude TardifDepartment of Medicine, Montreal Heart Institute, Montreal, QC, Canada.
Eric RhéaumeDepartment of Medicine, Montreal Heart Institute, Montreal, QC, Canada.
Hamood Al-KindiCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Sabin FilimonCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Cristina PopCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Jacques GenestCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Renzo CecereCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.
Adel SchwertaniCardiology and Cardiac Surgery, McGill University Health Center, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The progression of coronary atherosclerosis is an active and regulated process. The Wnt signaling pathway is thought to play an active role in the pathogenesis of several cardiovascular diseases; however, a better understanding of this system in atherosclerosis is yet to be unraveled. Methods: In this study, real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting were used to quantify the expression of Wnt3a, Wnt5a, and Wnt5b in the human coronary plaque, and immunohistochemistry was used to identify sites of local expression. To determine the pathologic significance of increased Wnt, human vascular smooth muscle cells (vSMCs) were treated with Wnt3a, Wnt5a, and Wnt5b recombinant proteins and assessed for changes in cell differentiation and function. Results: RT-PCR and Western blotting showed a significant increase in the expression of Wnt3a, Wnt5a, Wnt5b, and their receptors in diseased coronary arteries compared with that in non-diseased coronary arteries. Immunohistochemistry revealed an abundant expression of Wnt3a and Wnt5b in diseased coronary arteries, which contrasted with little or no signals in normal coronary arteries. Immunostaining of Wnt3a and Wnt5b was found largely in inflammatory cells and myointimal cells. The treatment of vSMCs with Wnt3a, Wnt5a, and Wnt5b resulted in increased vSMC differentiation, migration, calcification, oxidative stress, and impaired cholesterol handling. Conclusions: This study demonstrates the upregulation of three important members of canonical and non-canonical Wnt signaling pathways and their receptors in coronary atherosclerosis and shows an important role for these molecules in plaque development through increased cellular remodeling and impaired cholesterol handling.

Indexed as

cholesterol effluxhumanimmunohistochemistryRT-PCRvascular smooth muscle cells

Identifiers

PMID38586172
PMCPMC10995361

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.